{
    "organizations": [],
    "uuid": "41338dde080ffe76b4e099f656f2e1d229dae8a2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-4sc-ag-phase-ii-study-of-resminost/brief-4sc-ag-phase-ii-study-of-resminostat-in-biliary-tract-cancer-in-japan-initiated-idUSFWN1RV12A",
    "ord_in_thread": 0,
    "title": "BRIEF-4SC AG: Phase II Study Of Resminostat In Biliary Tract Cancer In Japan Initiated",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 19 (Reuters) - 4Sc AG:\n* DGAP-NEWS: 4SC AG: PHASE II STUDY OF 4SCâ€™S RESMINOSTAT IN BILIARY TRACT CANCER IN JAPAN IS INITIATED\n* FINAL RESULTS ARE EXPECTED TO BE AVAILABLE BY MID-2020 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-19T13:31:00.000+03:00",
    "crawled": "2018-04-20T12:17:46.028+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "4sc",
        "ag",
        "4sc",
        "ag",
        "phase",
        "ii",
        "study",
        "4sc",
        "resminostat",
        "biliary",
        "tract",
        "cancer",
        "japan",
        "initiated",
        "final",
        "result",
        "expected",
        "available",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}